Laboratory prediction of clinical chemotherapeutic drug resistance: a working model exemplified by acute leukaemia
- 31 December 1993
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (8) , 1208-1212
- https://doi.org/10.1016/s0959-8049(05)80316-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- PET scanning in oncologyEuropean Journal Of Cancer, 1992
- Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)International Journal of Cancer, 1992
- The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failureBritish Journal of Haematology, 1991
- Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assayThe Lancet, 1991
- Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemiaCurrent Opinion in Oncology, 1991
- A Critical Appraisal of the Predictive Value of In Vitro Chemosensitivity AssaysJNCI Journal of the National Cancer Institute, 1990
- Systemic Exposure to Mercaptopurine as a Prognostic Factor in Acute Lymphocytic Leukemia in ChildrenNew England Journal of Medicine, 1990
- Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assayLeukemia Research, 1989
- Clinical Pharmacokinetics-Pharmacodynamicsof Anticancer DrugsClinical Pharmacokinetics, 1989
- Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug ResistanceScience, 1988